Whalesbook
So, Max Financial Services ne fiscal year 2026 ke liye FY26 mein Annual Premium Equivalent (APE) mein zabardast 19.7% ki growth record ki hai, jo total ₹10,502 Cr tak pahunch gaya. Q4 FY26 toh aur bhi kamaal ka raha, APE mein sequential 31.5% aur year-on-year 18.3% ka jump dekha gaya. Ismein annuities mein 179% aur individual protection mein 52% ki tez izafa tha.
Lekin, asli twist yahan hai: Q4 FY26 ke liye Value of New Business (VNB) ₹1,014 Cr aaya, jo analyston ke expectations se 4% kam tha. Haalanki, is miss ke bawajood, company ka VNB margin Q4 mein solid 28.2% raha, aur poore saal ka margin 25.2% raha, jo company ke target range ke higher end ko touch karta hai. Company ne input tax credit jaise issues ko bhi smartly handle kiya product mix changes aur commission negotiations se.
Ab baat karte hain valuation ki. Max Financial ka P/E ratio 300 se 400 ke beech mein chal raha hai, market cap lagbhag ₹57,000-₹58,000 Cr hai. Yeh figure HDFC Life (P/E ~69.4) aur ICICI Prudential Life (P/E ~49.8) jaise bade rivals ke comparison mein bahut zyada hai. Max Financial ka claim settlement ratio 99.65% hai, lekin asset base $20.87 billion hai, jo HDFC Life ke $41.39 billion ya ICICI Prudential Life ke $33.89 billion se kaafi kam hai. Overall life insurance sector mein 12% growth dikh rahi hai, par policy volumes sirf 5% badhe hain, matlab growth mostly high-value products se aa rahi hai.
Analysts ke beech bhi is par mili-juli rai hai. Systematix ne 'Buy' rating aur ₹2,100 ka target diya hai, par VNB mein kami ne margin sustainability par sawal khade kar diye hain. HDFC Securities 'ADD' rating ke saath ₹1,420 target de raha hai, jabki Motilal Oswal ne 'Neutral' rating aur ₹1,020 target diya hai. Aur ek interesting baat, company ne apni Q4 FY26 earnings call cancel kar di, jo ki investors ke liye information ka ek important channel hota hai.
Company ka FY28 embedded value per share ₹956 hai, jiske basis par Systematix ne 2.6x valuation lagaya hai. Overall sentiment positive hi hai, 24 analysts 'Buy' keh rahe hain aur koi 'Sell' nahi. Average target ₹2,050.56 hai, matlab lagbhag 24% ka upside expected hai. Management ne kaha hai ki wo industry growth se 3-4% points zyada grow karne ka target rakhte hain. Strategic moves mein Axis Max Life ke saath amalgamation aur insurance business ko direct list karne ka plan bhi chal raha hai, aur ₹1,600 Cr tak fund raise karne ke liye QIP bhi aa sakta hai.